Sitagliptin Grindeks

Medicinal product

(Invented) name

Sitagliptin Grindeks

Active substance (s)

Sitagliptinas

Strength

100 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A10BH01, Sitagliptin

Marketing authorisation holder

AS Grindeks, Latvija

Date of authorisation

2022-02-03

Date of renewal

2026-09-18

Documents

4896-98_Sitagl_Grindeks_perr2026-09-18.docx

4896-98_pakuotes lapelis_2026-09-18.docx

Stage

Perregistruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

SE/H/2114/003/DC

Marketing authorisation procedure

Decentralizuota procedūra

Qualitative and quantitative composition

Tabletėje yra:	1 vnt.
Sitagliptinas	100 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
108042	94146	1094146	lizdinė plokštelė	N28		Receptinis	LT/1/22/4898/001	Netiekiama	2026-07-14	2026-12-31	Yes	2026-07-16	2026-12-31	Download
108043	94147	1094147	lizdinė plokštelė	N56		Receptinis	LT/1/22/4898/002	Netiekiama	-	-	No	-	-
108044	94148	1094148	lizdinė plokštelė	N98		Receptinis	LT/1/22/4898/003	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2026-09-18	Perregistruotas
2022-02-03	Registruotas